pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,982 catalysts · 3,126 8k filing · 1,811 grant · 1,000 device adverse event · 867 approval · 647 device 510k · 583 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 97 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-02×clear all
type
  • 8k filing3,126
  • grant1,811
  • device adverse event1,000
  • approval867
  • device 510k647
  • earnings583
device pma
497
  • device recall202
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 2, 2026

    50
    ›Feb 2, 2026approval191d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval191d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval191d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval191d agoMETHYLENE BLUE — FDA approvalMETHYLENE BLUE

    Sponsor: ZYDUS LIFESCIENCES. Form: SOLUTION. Route: INTRAVENOUS

    full page →METHYLENE BLUE →fda approvals ↗
    ›Feb 2, 2026approval191d agoTYRUKO (NATALIZUMAB-SZTN) — FDA approvalnatalizumab biosimilar

    Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

    full page →natalizumab biosimilar →fda approvals ↗
    ›Feb 2, 2026approval191d agoLENALIDOMIDE — FDA approvalLENALIDOMIDE

    Sponsor: CIPLA. Form: CAPSULE. Route: ORAL

    full page →LENALIDOMIDE →fda approvals ↗
    ›Feb 2, 2026approval191d agoPRIMAQUINE (PRIMAQUINE PHOSPHATE) — FDA approvalprimaquine phosphate

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →primaquine phosphate →fda approvals ↗
    ›Feb 2, 2026approval191d agoNORLIQVA (AMLODIPINE BESYLATE) — FDA approvalChina Resources Saike Pharmaceutical Co Ltd

    Sponsor: CMP DEV LLC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval191d agoAIR — FDA approval

    Sponsor: GENERAL AIR SERVICE & SUPPLY COMPANY. Form: GAS. Route: INHALATION

    full page →fda approvals ↗
    ›Feb 2, 2026approval191d agoPUR-WASH (PURIFIED WATER) — FDA approval

    Sponsor: NIAGARA PHARMS. Form: SOLUTION. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Feb 2, 2026approval191d agoFIDAXOMICIN — FDA approvalDificid

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →Dificid →fda approvals ↗
    ›Feb 2, 2026approval191d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Feb 2, 2026approval191d agoMIRTAZAPINE — FDA approvalmirtazapine ODT

    Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

    full page →mirtazapine ODT →fda approvals ↗
    ›Feb 2, 2026approval191d agoESTRADIOL — FDA approvalLong Grove Pharmaceuticals LLC

    Sponsor: LONG GROVE PHARMS. Form: GEL, METERED. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Feb 2, 2026approval191d agoPREGABALIN — FDA approvalViatris Inc

    Sponsor: CHANGZHOU PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 2, 2026device 510k191d agoNano-X Imaging , Ltd. — TAP2D (510k cleared)Nano-X Imaging Ltd.

    Product code: IZF. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 2, 2026device 510k191d agoChengdu Besmile Medical Technology Co., Ltd. — BIORES Dental Implant System (510k cleared)

    Product code: DZE. Advisory committee: Dental. Type: Abbreviated

    full page →fda device 510k ↗
    ›Feb 2, 2026device 510k191d agoOxehealth Limited — Vital Signs (510k cleared)

    Product code: QME. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 2, 2026device 510k191d agoBeijing Kreate Medical Co., Ltd. — Redermax Antibacterial Wound Matrix (510k cleared)

    Product code: FRO. Advisory committee: Unknown. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 2, 2026device 510k191d agoAsahi Intecc Co., Ltd. — CHIKAI Nexus petit (510k cleared)

    Product code: MOF. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 2, 2026device pma191d agoPhilips Medical Systems, Inc. — HeartStart OnSite Defibrillator (Model M5066A) and HeartStart Home Defibrillator (Model M5068A) (PMA supplement)MERIT MEDICAL SYSTEMS INC

    Supplement type: 30-Day Notice. Product code: NSA. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 2, 2026device pma191d agoCooperVision, Inc. — Biofmity XR Torie (comfilcon A) Soft (Hydrophilic) Contact Lenses for Extended Wear (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Feb 2, 2026device pma191d agoEdwards Lifesciences, LLC — Edwards EVOQUE Tricuspid Valve Replacement System (PMA supplement)Edwards Lifesciences Corp

    Supplement type: 30-Day Notice. Product code: NPW. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 2, 2026device pma191d agoPhilips Medical Systems — HeartStart FRx Defibrillator (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MKJ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 2, 2026device recall191d agoB Braun Medical Inc device recall (Cls II)B. Braun Medical Inc

    Brand Name: B. Braun Product Name: 21GA WINGED INF SET Model/Catalog Number: 7M2802 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A — Reason: The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 2, 2026device recall191d agoHowmedica Osteonics Corp. device recall (Cls II)

    MICS3 Angled Sagittal Saw Attachment; Part Number: 210490 — Reason: A potential issue was identified with the torque strength on the external screws of the MICS3 Angled Sagittal Saw Attachment. These screws, which secure the cover to the Angled Saw Housing, may loosen during use and detach from the attachment. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 2, 2026device recall191d agoB Braun Medical Inc device recall (Cls II)B. Braun Medical Inc

    Brand Name: B. Braun Product Name: 21GA WINGED INFUSION, SINGLE PK Model/Catalog Number: 7A3842 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A — Reason: The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 2, 2026device recall191d agoB Braun Medical Inc device recall (Cls II)B. Braun Medical Inc

    Brand Name: B. Braun Product Name: BBraun Medical 21G X4.4CM Winged INF Model/Catalog Number: 7B3050 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A — Reason: The potential for the needle tip to be dull/blunt, difficult to advance, and/or break. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF GEORGIA — Establishing a cystic fibrosis ferret model of chronic Mycobacterium abscessu...

    AI grant. $224,857. PI: Tuhina Gupta

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoGEORGIA INSTITUTE OF TECHNOLOGY — Controlled Delivery of Adjuvanted Multivalent Fusion Peptide Focused HIV Vacc...

    AI grant. $725,241. PI: M.G. Finn

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoHARVARD UNIVERSITY — Discovery of antimicrobial metabolites from the human gut microbiota using hi...

    AI grant. $463,375. PI: Emily Patricia Balskus

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoEMORY UNIVERSITY — Inducible Hepatic-Associated Lymphoid Tissue (iHALT): generating and maintain...Emory University

    AI grant. $922,840. PI: Arash Grakoui

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoSTATE UNIVERSITY NEW YORK STONY BROOK — Discrimination learning and neural dynamics in gustatory cortical circuits

    DC grant. $638,908. PI: Alfredo Fontanini

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoWASHINGTON UNIVERSITY — Myelin and non-myelin immune responses in Multiple sclerosis

    AI grant. $624,300. PI: Naresha Saligrama

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoEMORY UNIVERSITY — Investigating relationships between naturalistic light exposure and sleepEmory University

    HL grant. $248,705. PI: Danielle A. Wallace

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoWASHINGTON UNIVERSITY — Sensing of viral infections in C. elegans

    AI grant. $427,625. PI: DAVID WANG

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoOHIO STATE UNIVERSITY — Non-siderophore function of peroxisomes in Histoplasma pathogenesis

    AI grant. $354,416. PI: Chad A Rappleye

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoLOUISIANA STATE UNIV A&M COL BATON ROUGE — Identification of RNAi-independent antiviral genes through biased genetic scr...

    AI grant. $412,500. PI: Rui Lu

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Assessing the longitudinal impact of Mediterranean diet interventions to redu...University of California San Diego

    AG grant. $43,784. PI: Lucas Noah Patel

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Reversing Graft Rejection by Targeting Innate Immune Memory with Novel Nanobi...

    AI grant. $452,835. PI: Geoffrey Camirand

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF WISCONSIN-MADISON — The significant effects of butyrate on Clostridioides difficile fitness and p...

    AI grant. $753,899. PI: Andrew John Hryckowian

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUT SOUTHWESTERN MEDICAL CENTER — Oligoadenylate synthetase (OAS) in intestinal immunity

    AI grant. $456,500. PI: Nan Yan

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoVIRGINIA POLYTECHNIC INST AND ST UNIV — Discovery and Development of antisense therapeutics for Clostridioides diffic...

    AI grant. $437,541. PI: Mohamed Seleem

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoHARVARD MEDICAL SCHOOL — Elucidating the molecular and functional diversity of dorsal root ganglia som...

    NS grant. $120,501. PI: Scott Andrew Shuster

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Living Microrobot for Active Therapeutic Delivery to Treat Severe Pulmonary I...University of California San Diego

    AI grant. $720,035. PI: Victor Nizet

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Characterization of CD4 T cells targeting liver and blood stage malaria epitopesUniversity of California San Francisco

    AI grant. $895,740. PI: MARGARET E FEENEY

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF CHICAGO — Intestinal Epithelial Heat Shock Protein 25/27 integrates host immune and mic...

    DK grant. $770,995. PI: EUGENE B CHANG

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF FLORIDA — Renal and adrenal actions of the clock protein PER1 in salt-sensitive hyperte...University of Florida

    DK grant. $663,104. PI: Michelle L Gumz

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoOREGON STATE UNIVERSITY — Biosynthesis of ureido containing natural products: Mechanistic studies and s...

    AI grant. $495,688. PI: Benjamin Philmus

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Targeted Depalmitoylation of Presynaptic CaV channels in Health and Disease

    NS grant. $589,156. PI: Manu Ben Johny

    full page →nih reporter ↗
    ← prev
    page 1 of 180
    next →
    $MMSI91.54+1.99%
    $VTRS16.20-0.49%
    $EW91.33-2.47%
    $NNOX1.7300+1.17%